Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial
David Jayne, Brad Rovin, Eduardo Mysler, Richard Furie, Frédéric Houssiau, Teodora Trasieva, Jacob Knagenhjelm, Erik Schwetje, Weifeng Tang, Raj Tummala, Catharina Lindholm
Lupus Science & Medicine Aug 2023, 10 (2) e000910; DOI: 10.1136/lupus-2023-000910